Chronic aminoguanidine attenuates renal dysfunction and injury in aging rats

American Journal of Hypertension

Volumn 12, Issue 5, 1999, Pages 492-498

  Reckelhoff, Jane F ^a   Hennington, Bettye Sue ^a   Kanji, Vijaya ^a   Racusen, Lorraine C ^b   Schmidt, Ann Marie ^c   Yan, Shi Du ^c   Morrow, Jason ^d   Roberts II, L Jackson ^d   Salahudeen, Abdulla K ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Columbia Univ Coll Phys Surgs ^*  (United States)

^d VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Advanced glycosylation end products; F2 isoprostanes; Free radicals; Glomerular filtration rate; Lipid peroxidation; Renal plasma flow

Indexed keywords

AMINOGUANIDINE; ISOPROSTANE; NITRIC OXIDE SYNTHASE;

AGING; ANIMAL EXPERIMENT; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; DRUG EFFECT; ENZYME INHIBITION; GLOMERULOSCLEROSIS; GLOMERULUS FILTRATION RATE; GLYCOSYLATION; KIDNEY FUNCTION; KIDNEY INJURY; KIDNEY PLASMA FLOW; LIPID PEROXIDATION; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT;

AGING; ANIMALS; BIOLOGICAL MARKERS; BLOTTING, WESTERN; DINOPROST; DISEASE MODELS, ANIMAL; ENZYME INHIBITORS; F2-ISOPROSTANES; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; GLYCOSYLATION END PRODUCTS, ADVANCED; GUANIDINES; KIDNEY; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; RENAL PLASMA FLOW;

EID: 0033003723     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(98)00264-7     Document Type: Article

References (31)

1. Lindemann R.D., Goldman R. Anatomic and physiologic age changes in the kidney. Exp Gerontol. 21:1986;379-386.
2. Levi M., Rowe J.W. Renal function and dysfunction in aging. Seldin D.W., Giebisch G. The Kidney Physiology and Pathophysiology . 1992;3433-3456 Raven Press, Ltd, New York.
3. Goldstein R.S., Tarloff J.B., Hook J.B. Age-related nephropathy in laboratory rats. FASEB J. 2:1988;2241-2251.
4. Leibovitz B.E., Siegel B.V. Aspects of free radical reactions in biological systems aging . J Gerontol. 35:1990;45-56.
5. Nath K.A., Salahudeen A.K. Induction of renal growth and injury in the intact rat kidney by dietary deficiency of antioxidants. J Clin Invest. 86:1990;1179-1192.
6. Angulo J., Sanchez-Ferrer C.F., Peiro C., et al. Impairment of endothelium-dependent relaxation by increasing percentages of glycosylated hemoglobin. Possible mechanisms involved. Hypertension. 28:1996;583-592.
7. Morrow J.D., Roberts J.L. II. The isoprostanes current knowledge and directions for future research . Biochem Pharmacol. 51:1996;1-9.
8. Reckelhoff J.F., Kanji V., Racusen L.C., et al. Vitamin E ameliorates enhanced renal lipid peroxidation and accumulation of F2-isoprostanes in aging kidneys. Am J Physiol. 274:1998;R767-R774.
9. Morris S.M. Jr, Billiar T.R. New insights into the regulation of inducible nitric oxide synthase. Am J Physiol. 266:1994;E829-E839.
10. Pfeilschifter J., Kunz D., Muhl H. Nitric oxide an inflammatory mediator of glomerular mesangial cells . Nephron. 64:1993;518-524.
11. Corbett J.A., Tilton R.G., Chang K., et al. Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunction. Diabetes. 41:1992;552-556.
12. Li Y.M., Steffes M.W., Donnelly T., et al. Prevention of cardiovascular and renal pathology of aging by the advanced glycation inhibitor aminoguanidine. Proc Natl Acad Sci USA. 93:1996;3902-3907.
13. Reckelhoff J.F., Hennington B.S., Moore A.G., et al. Gender differences in renal NO system dissociation between expression of endothelial NO synthase and renal hemodynamic response to NO synthase inhibition . Am J Hypertens. 11:1998;97-104.
14. Laszlo F., Evans S.M., Whittle B.J. Aminoguanidine inhibits both constitutive and inducible nitric oxide synthase isoforms in rat intestinal microvasculature in vivo. Eur J Pharm. 272:1995;169-175.
15. Reckelhoff J.F., Kellum J.A., Blanchard E.J., et al. Changes in nitric oxide precursor, L-arginine, and metabolites, nitrate and nitrite, with aging. Life Sci. 55:1994;1895-1902.
16. Ichikawa I., Maddox D.A., Cogan M.G., Brenner B.M. Dynamics of glomerular ultrafiltration in euvolemic Munich Wistar rats. Renal Physiol. 1:1978;121-131.
17. Reckelhoff JF, Manning, Jr: Role of endothelial-derived nitric oxide in the control of the renal micovasculature in aging male rats. Am J Physiol 1993;265:R1126-R1131.
18. Reckelhoff J.F., Kellum J.A. Jr, Racusen L.C., Hildebrandt D.A. Long term dietary supplementation with L-arginine prevents age-related reduction in renal function. Am J Physiol. 272:1997;R1768-R1774.
19. Salahudeen A., Badr K., Morrow J., Roberts J. II. Hydrogen peroxide induces 21-aminosteroid-inhibitable F2-isosprostane production and cytolysis in renal tubular epithelial cells. J Am Soc Nephrol. 6:1995;1300-1303.
20. Morrow J.D., Hill K.E., Burk R.F., et al. A series of prostaglandin F2-like compounds are produced in vivo in humans by a noncyclooxygenase, free radical-catalyzed mechanism. Proc Natl Acad Sci USA. 87:1990;9383-9387.
21. Morrow J.D., Roberts L.J. II. Mass spectrometry of prostanoids F2-isoprostanes produced by non-cyclooxygenase free radical catalyzed mechanism . Meth Enzymol. 233:1994;163-174.
22. Schmidt A.M., Hori O., Bret J., et al. Cellular receptors for advanced glycation end products. Implications for induction of oxidant stress and cellular dysfunction in the pathogenesis of vascular lesions. . Arterioscl Thromb. 14:1994;1521-1528.
23. Miyata T., Hori O., Zhang J., et al. The receptor for advanced glycation end products (RAGE) is a central mediator of the interaction of AGE-B2 microglobulin with human mononuclear phagocytes via an oxidant-sensitive pathway. J Clin Invest. 98:1996;1088-1094.
24. Griffiths M.J.D., Messent M., MacAllister R.J., Evans T.W. Aminoguanidine selectively inhibits inducible nitric oxide synthase. Br J Pharmacol. 110:1993;963-968.
25. Silva I.J., Azevedo M.S., Manso C.F. Superoxide anion radical generation during the oxidation of various amines by diamine oxidase. Free Rad Res. 24:1996;167-175.
26. Philis-Tsimikas A., Parthasarathy S., Picard S., et al. Aminoguanidine has both pro-oxidant and antioxidant activity toward LDL. Arterioscler Thromb Vasc Biol. 15:1995;367-376.
27. Takahashi K., Nammour T.M., Fukunaga M., et al. Glomerular action of a free radical generated novel prostaglandin, 8-epi-prostaglandin F2-alpha, in the rat. J Clin Invest. 90:1992;136-141.
28. Morrow J.D., Arrad J.A., Boss H.L.J., et al. Non-cyclooxygenase derived prostanoids (F2-isoprostanes) are found in situ on phospholipids. Proc Natl Acad Sci USA. 89:1992;10721-10725.
29. Soulis-Liparota T., Cooper M.E., Dunlop M., Jerums G. The relative roles of advanced glycation, oxidation and aldose reductase inhibition in the development of experimental diabetic nephropathy in the Sprague-Dawley rat. Diabetol. 39:1995;387-394.
30. DiSilvestro R.A., Jones A.A., Smith D., Wildman R. Plasma diamine oxidase activities in renal dialysis patients, a human with spontaneous copper deficiency and marginally copper deficient rats. Clin Biochem. 30:1997;559-563.
31. Mattson D.L., Lu S., Nakanishi K., et al. Effect of chronic renal medullary nitric oxide inhibition on blood pressure. Am J Physiol. 266:1994;H1918-H1926.